Nuveen Churchill price target lowered to $16 from $18 at Citizens

Citizens lowered the firm’s price target on Nuveen Churchill (NCDL) to $16 from $18 and keeps an Outperform rating on the shares. The private capital industry is adjusting to a new operating backdrop marked by lower interest rates, creating mixed impacts across products but underscoring the importance of understanding underlying earnings drivers, the analyst tells investors in a research note. Scale and diversification should support resilient growth into 2026, making manager selection increasingly critical despite expectations for continued industry expansion, the firm says.